We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$14B
AUM Growth
-$163M
Cap. Flow
-$588M
Cap. Flow %
-4.21%
Top 10 Hldgs %
55.46%
Holding
59
New
12
Increased
13
Reduced
11
Closed
9

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$1.12B
2
ABBV icon
AbbVie
ABBV
+$416M
3
HRI icon
Herc Holdings
HRI
+$365M
4
LH icon
Labcorp
LH
+$171M
5
FLEX icon
Flex
FLEX
+$116M

Sector Composition

Rank Sector Weight
1 Healthcare 52.98%
2 Communication Services 11.74%
3 Materials 7.75%
4 Technology 6.93%
5 Industrials 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOUS
26
DELISTED
Anywhere Real Estate
HOUS
$155M 1.11%
6,002,557
FDC
27
DELISTED
First Data Corporation
FDC
$152M 1.09%
11,537,629
+4,285,775
+59% +$55.2M
VER
28
DELISTED
VEREIT, Inc.
VER
$149M 1.07%
2,878,022
-175,620
-6% -$9.14M
LBTYA icon
29
Liberty Global Class A
LBTYA
$3.59B
$147M 1.05%
4,286,651
+140,311
+3% +$4.45M
DD
30
DELISTED
Du Pont De Nemours E I
DD
$122M 0.87%
1,821,983
UHS icon
31
Universal Health Services
UHS
$10.2B
$117M 0.84%
+950,390
New +$120M
TEVA icon
32
Teva Pharmaceuticals
TEVA
$40.4B
$100M 0.72%
2,176,144
-906,703
-29% -$47.3M
TWX
33
DELISTED
Time Warner Inc
TWX
$100M 0.72%
+1,257,086
New +$98.2M
AN icon
34
AutoNation
AN
$7.7B
$91.9M 0.66%
1,885,833
MTOR
35
DELISTED
MERITOR, Inc.
MTOR
$90.5M 0.65%
8,126,817
ENDP
36
DELISTED
Endo International plc
ENDP
$85.7M 0.61%
+4,250,784
New +$84.5M
ESI icon
37
Element Solutions
ESI
$8.48B
$83.5M 0.6%
+10,294,598
New +$91.9M
AAPL icon
38
Apple
AAPL
$4.97T
$76.8M 0.55%
+2,716,852
New +$71.9M
HPE icon
39
Hewlett Packard
HPE
$58.8B
$68.6M 0.49%
+5,185,310
New +$64M
PHH
40
DELISTED
PHH Corporation
PHH
$68.2M 0.49%
4,719,361
-95,600
-2% -$1.4M
MRVL icon
41
Marvell Technology
MRVL
$147B
$60.7M 0.43%
4,572,703
+313,678
+7% +$3.68M
CCEP icon
42
Coca-Cola Europacific Partners
CCEP
$49.1B
$56.1M 0.4%
+1,405,892
New +$53.6M
ABG icon
43
Asbury Automotive
ABG
$4.62B
$54.3M 0.39%
974,731
ESRX
44
DELISTED
Express Scripts Holding Company
ESRX
$45.2M 0.32%
640,960
+568,838
+789% +$42.5M
BEAV
45
DELISTED
B/E Aerospace Inc
BEAV
$44.1M 0.32%
+854,335
New +$41.3M
TLRD
46
DELISTED
Tailored Brands, Inc.
TLRD
$37.7M 0.27%
+2,400,000
New +$34.9M
WTW icon
47
Willis Towers Watson
WTW
$29.8B
$35.6M 0.25%
+267,951
New +$33.4M
KND
48
DELISTED
Kindred Healthcare
KND
$20.4M 0.15%
1,999,713
LPNT
49
DELISTED
LifePoint Health, Inc.
LPNT
$14.8M 0.11%
+250,000
New +$15M
C.WS.A
50
DELISTED
Citigroup Inc
C.WS.A
$419K ﹤0.01%
8,031,020

Similar funds

Glenview Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Glenview Capital Management held 59 positions worth $14B, down 1.1% from $14.1B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Glenview Capital Management withdrew a net $588M in Q3 2016, closing 9 positions and reducing 11 holdings. Its most notable exit was Monsanto Co, an estimated $1.12B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 51% a quarter earlier, followed by Communication Services and Materials.

Against the trend, Glenview Capital Management opened a new position in Hertz Global Holdings, Inc. worth $265M.

  • Glenview Capital Management's largest Q3 2016 buy was Hertz Global Holdings, Inc.: 7,599,786 shares worth $265M.
  • Glenview Capital Management added most to Paramount Global Class B in Q3 2016, an estimated $329M increase.
  • Glenview Capital Management's biggest Q3 2016 reduction was AbbVie, cutting an estimated $416M.
  • Glenview Capital Management fully exited Monsanto Co in Q3 2016, selling an estimated $1.12B.
  • Glenview Capital Management's ten largest holdings make up 55% of its $14B portfolio in Q3 2016.
  • Glenview Capital Management opened 12 new positions and closed 9 in Q3 2016.
  • Glenview Capital Management's portfolio value fell 1.1% quarter-over-quarter to $14B.

Based on Glenview Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.